Immediate Impact

2 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Why do patients with cancer die?
2024 Standout
2 intermediate papers

Works of Giulia Cervetti being referenced

ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial
2009
Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients
2005

Author Peers

Author Last Decade Papers Cites
Giulia Cervetti 255 336 248 37 601
Eleonora Russo 140 184 140 28 525
Hirotaka Takasaki 147 313 243 59 714
Sarah M. Larson 194 197 334 69 724
S. Molica 182 280 192 25 534
Ken Ohmachi 204 397 335 46 581
Judith Huerta‐Guzmán 94 396 396 42 655
Guido Gini 89 233 202 36 612
Hari Menon 204 171 229 69 584
A. M. Gianni 82 200 293 26 614
Itsuko Nakamichi 180 299 265 28 667

All Works

Loading papers...

Rankless by CCL
2026